No Data
TC Biopharm Shares Are Trading Higher After Completing Cohort A in Its ACHIEVE Phase 2B Clinical Trial.
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading
TC BioPharm Completes Initial Group B Dosing in Trial of TCB008 to Treat Acute Myeloid Leukemia
TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial
EXCLUSIVE: Nano-Cap TC BioPharm Concludes Initial Cohort B Patient Dosing In Mid-Stage Leukemia Trial, Data Readout By End Of 2025
Express News | EXCLUSIVE: TC BioPharm Tells Benzinga Co. Announces Successful Completion Of Initial Cohort B Patient Dosing In The ACHIEVE Clinical Trial
HugoV : got stopped out and than it rosed
70065450 : I think this is the bottom